ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1435	National Cancer Institute	Html	en	Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood extracranial germ cell tumors.	testicular germ cell 0.206027 treatment 0.243869 germ cell tumors 0.902772 stage 0.204984 extracranial germ cell 0.708761	ovarian germ cell 0.212137 childhood extracranial germ 0.398861 cancer 0.399843 clinical trials 0.265215	CLICK HERE
1568	National Cancer Institute	Html	en	Gastrointestinal Carcinoid Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gastrointestinal carcinoid tumors.	carcinoid tumor cells 0.278965 metastatic GI carcinoid 0.238039 treatment 0.556764 cancer treatment 0.277356 malignant tumor cells 0.240006 general information 0.281992 GI carcinoid tumors 0.692008 Hormone therapy 0.212489 Lung Cancer Treatment 0.223918 NCI-supported cancer 0.254433 cancer cells 0.281516 stomach 0.228344 hepatic artery 0.21097 body 0.300003 type 0.211866 PDQ cancer information 0.277061 clinical trial search 0.358585 carcinoid tumor spreads 0.266506 treatment clinical trials 0.240478 recurrent GI carcinoid 0.223511 National Cancer Institute 0.243506 clinical trials 0.834392 tumor cells 0.308788	Carcinoid Tumors Treatment 0.268829 cancer information summary 0.243151 clinical trial 0.501578 new treatment 0.293328 Rectal Cancer Treatment 0.224504 liver 0.203338 gastrointestinal carcinoid tumor 0.314953 patients 0.237822 carcinoid heart syndrome 0.215848 carcinoid tumor tissue 0.264996 carcinoid syndrome 0.334872 metastatic tumor 0.206035 blood 0.210445 cancer clinical trials 0.359168 lymph nodes 0.28707 carcinoid tumors 0.943574 radiation therapy 0.236209 internal radiation therapy 0.21238 cancer 0.673084 information 0.294151 small intestine 0.264836 gastrointestinal carcinoid tumors 0.573326 Intestine Cancer Treatment 0.236505	CLICK HERE
1622	National Cancer Institute	Html	en	PC-SPES (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of PC-SPES as a treatment for prostate cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	AI prostate cancer 0.303125 herbal supplement PC-SPES 0.226052 androgen receptor 0.217805 United States 0.217375 AI human prostate 0.265687 tumor cell lines 0.239745 prostate cancer cell 0.651484 cell growth 0.337694 PC-SPES mixture 0.233921 human cancer cells 0.227728 cancer cell lines 0.814613 active agents 0.216957 cell cycle arrest 0.28032 human ovarian cancer 0.210983 PC-SPES 0.565565 metastatic prostate cancer 0.246109 human breast cancer 0.222738 prostate cancer model 0.251984 prostate specific gene 0.222494 PSA levels 0.422352 Prostate Cancer Treatment 0.30307 LNCaP prostate cancer 0.263951 human prostate LNCaP 0.252103 aggregate PC-SPES mixture 0.22369	prostate cancer cells 0.283954 cell cycle effects 0.221846 cell cycle 0.301026 Abstract 0.225583 colon cancer growth 0.213185 DU-145 prostate cancer 0.299116 prostate specific antigen 0.22926 prostate cancer patients 0.5128 PSA expression 0.28316 hormone-insensitive prostate cancer 0.250196 vitro 0.242733 vitro estrogenic activity. 0.21527 LNCaP cells 0.250769 prostate cancer 0.975741 effects 0.268243 pretreatment PSA levels 0.220575 Cancer Lett 0.216432 reduced PSA expression 0.210327 serum PSA levels 0.222831 human cancer cell 0.295651 Scutellaria baicalensis 0.227162 PC-SPES capsules 0.218201 human prostate cancer 0.330615	CLICK HERE
1678	National Cancer Institute	Html	en	Communication in Cancer Care (PDQ®)–Health Professional Version	Effective cancer communication between the health care team, cancer patients, and their family is important. Learn about communication skills that support a patient-centered practice and how to talk with adults and children about their diagnosis, prognosis, and transition to end-of-life care in this expert-reviewed summary.	female breast cancer 0.57505 eligible patients 0.564938 bad news 0.743613 medical decision making 0.58503 physicians 0.592367 direct patient care 0.564892 diverse cancer patients 0.603459 clinical trials 0.61877 communication 0.630971 early-stage breast cancer 0.592631 patients cultural beliefs 0.582353 breast cancer experience 0.564126 breast cancer treatment 0.579002 breast cancer patients 0.646574 patients 0.906881 cancer patients 0.64886 white patients 0.564203 cancer diagnosis 0.569139 health care costs 0.565569 cancer patients report 0.596785 decision making 0.744128 breast cancer therapy 0.566081 treatment decision making 0.568266 older breast cancer 0.566807 care 0.590659	treatment 0.626966 American oncology patients 0.58299 study 0.656108 patient communication preferences 0.600601 cancer disclosure issues 0.56732 African American patients 0.584216 different information styles 0.572854 Asian American women 0.565505 patient decision making 0.57769 black patients 0.564183 younger patients 0.563325 high information needs 0.57343 health care 0.579997 patient information style 0.59028 older patients 0.579527 initial cancer diagnosis 0.562722 Cancer care 0.562573 breast cancer 0.780881 specific treatment information 0.578443 patient satisfaction 0.579033 information patients 0.586119 treatment options 0.585641 rural American patients 0.584504 pessimistic information people 0.566128	CLICK HERE
1758	National Cancer Institute	Html	en	Radiation Therapy for Cancer	A fact sheet that defines the different types of radiation therapy and discusses scientific advances that improve the effectiveness of this treatment.	radiation beam-shaping devices 0.405709 cancer treatment 0.383308 radiation damage 0.388785 continuous low-dose radiation 0.400269 whole-brain radiation therapy 0.419192 clinical trials 0.384103 brachytherapy 0.350611 smaller radiation fields 0.402818 high-energy radiation 0.421756 radiation therapy kill 0.43549 neoadjuvant radiation 0.393279 high radiation doses 0.407974 radiation monitors 0.387758 exact radiation plan 0.408331 normal tissue 0.471558 Image-guided radiation therapy 0.421303 body radiation therapy 0.425833 radiation therapy machine 0.421108 radiation therapy 0.980996 radiation doses 0.416676 treatment 0.462098 cancer cells 0.462619 radiation exposure 0.418968 3-dimensional conformal radiation therapy 0.42971 radiation oncologists 0.38961	adjuvant radiation therapy 0.411117 treatment planning 0.350359 total radiation dose 0.44244 radiation energy 0.401543 standard external-beam radiation 0.404865 patient 0.382556 radiation source 0.404836 radiation side effects 0.390501 Stereotactic body radiation 0.413552 delivers radiation therapy 0.41809 palliative radiation therapy 0.444425 radiation delivery 0.401163 Intensity-modulated radiation therapy 0.422003 external-beam radiation therapy 0.67618 publications Radiation Therapy 0.411985 systemic radiation therapy 0.554464 radiation treatment 0.409027 traditional radiation therapy 0.410276 radiation sources 0.408845 electromagnetic radiation 0.398457 tumor 0.381132 intraoperative radiation therapy 0.411493 internal radiation therapy 0.476394 radiation therapy drugs 0.418615	CLICK HERE
1773	National Cancer Institute	Html	es	Trastornos del sueño (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas de los trastornos del sueño de las personas con cáncer y su manejo.	American Academy 0.62007 sleep disturbance 0.546203 Sateia MJ 0.426893 Sleep Disturbance Scale 0.434259 CdV Mejoras 0.428861 mg riesgo 0.50361 National Sleep Foundation 0.473914 Sleep Quality Index 0.466452 Simard S 0.452533 neglected problem 0.428741 sueño mor 0.943385 risk factors 0.426951 sleep-wake disturbances 0.458084 Sleep Disorders 0.45951 Oncol Nurs 0.45478 PDQ Delirium 0.436712 coordinación motriz 0.436956 sueño diario 0.570793 sleep disruption 0.458489 Insomnia Severity Index 0.446987 patients with 0.455594 Hirshkowitz M 0.42487 Pittsburgh Sleep Quality 0.464939 Insomnia Severity 0.454434 sueño frente 0.501612	Roscoe JA 0.426353 Oncol Nurs Forum 0.453234 Morin CM 0.426813 sueño categoría 0.493243 Care Cancer 0.439262 Palesh OG 0.427427 ECA Control 0.495325 Savard J 0.54747 Sleep Medicine review 0.435342 Mustian KM 0.426387 patients based 0.427546 Rochester Cancer Center-Community 0.462263 Clinical Oncology Program 0.450218 sleep regulation 0.427006 sueño nmor 0.697198 Clin Oncol 0.506515 Clin North Am 0.455007 estadio i–iii 0.467766 Center-Community Clinical Oncology 0.451231 psychological associations 0.42745 Cancer Center-Community Clinical 0.464249 Sleep Medicine 0.709305 Med Clin North 0.456379 Sleep Disorders Classification 0.439634	CLICK HERE
1820	National Cancer Institute	Html	es	Tratamiento del rabdomiosarcoma infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del rabdomiosarcoma infantil.	rhabdomyosarcoma patient 0.0299377 embryonal rhabdomyosarcoma with 0.0333796 Cancer Res Clin 0.0162353 results from 0.01769 prognostic factors 0.0264003 spindle cell rhabdomyosarcomas 0.019783 Tissue Sarcoma Study 0.0288157 Sin embargo 0.0245253 intergroup rhabdomyosarcoma studies 0.0596756 Rhabdomyosarcoma With Low-Risk 0.0321933 molecularly indistinguishable from 0.0208039 metastatic rhabdomyosarcomas 0.0266236 Intergroup Rhabdomyosarcoma Committee 0.0168747 Group Soft Tissue 0.018066 Alveolar Rhabdomyosarcoma With 0.0442707 lymph node biopsy 0.0162009 patients with nonmetastatic 0.037603 patients with 0.0939786 Rhabdomyosarcoma Study Group 0.0347209 oncology group report 0.0309001 soft tissue sarcoma 0.90779 Intergroup Rhabdomyosarcoma Study 0.199615 Pappo AS 0.0234049 intergroup rhabdomyosarcoma study-iv 0.0268353 fusion status 0.031797	ganglio linfático centinela 0.0180392 pediatric rhabdomyosarcoma 0.0285282 Ferrari A 0.032325 Pediatr Blood Cancer 0.298233 report from 0.448539 National Cancer Institute 0.0204895 rhabdomyosarcoma with 0.0598247 With Low-Risk Clinical 0.0191066 características histológicas 0.572518 Cooperative Soft Tissue 0.0269183 Med Genet 0.0241399 Pediatr Surg 0.0232296 Pediatr Hematol Oncol 0.0201008 Clin Oncol 0.467523 Med Pediatr Oncol 0.0214986 rhabdomyosarcoma is clinically 0.0229347 tissue sarcoma committee 0.33808 tumores embrionarios 0.0364557 alveolar rhabdomyosarcoma 0.101176 children's oncology group 0.895264 rabdomiosarcoma embrionario vs 0.0329873 rabdomiosarcoma botrioide 0.0236888 intergroup rhabdomyosarcoma 0.352028 embryonal rhabdomyosarcoma 0.0962874	CLICK HERE
3446	National Cancer Institute	Html	es	Consumo de cigarrillo: riesgos para la salud y cómo dejar de fumar (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre la investigación y pautas que se enfocan en la prevención y el abandono del tabaquismo.	efectos secundarios comentarios 0.501986 leucemia mieloide 0.427415 metabolitos carcinógenos 0.42791 bupropión marca dosis 0.454219 grupo vareniclina 0.463468 importancia clínica 0.450606 MVL Nicorette DS 0.439222 pruebas directas 0.619014 MVL Nicoderm CQ 0.440426 MVL Commit 0.42718 Sin embargo 0.467903 muertes prematuras 0.469229 largo plazo 0.764238 cessation interventions among 0.449671 Lung Health Study 0.44169 Lancaster T 0.545862 defunciones prematuras 0.434559 bupropión mejora 0.45245 Stead LF 0.482703 orientación mejora 0.429664 bupropión ap 0.446903 Nicotine replacement therapy 0.444158 semanas insomnio 0.443481 vareniclina mejora 0.477582 Estados Unidos 0.989049	polacrilex marca dosis 0.434801 insomnio riesgo 0.427937 smoking cessation 0.872626 salud pública 0.590985 Database Syst Rev 0.689429 abandono gradual versus 0.477395 nicotina marca dosis 0.473496 beneficio hipotético implícito 0.443214 Treating Tobacco Use 0.44172 versus trn 0.451335 MVL Nicorette 0.462807 mejores tasas 0.435725 Community Intervention Trial 0.530278 Marca Dosis Efectos 0.591077 alta calidad 0.516955 efectos secundarios advertencias 0.436485 compuestos carcinógenos 0.426773 tasas promedio 0.433836 aductos carcinógenos 0.42846 planta cytisus laburnum 0.434664 antidepresivo bupropión 0.449342 cuello uterino 0.576293 MVL Nicotrol 0.425887 Surveillance Modeling Network 0.440037	CLICK HERE
3573	National Cancer Institute	Html	en	Immunotherapy: Using the Immune System to Treat Cancer	Immunotherapies are treatments that restore or enhance the immune system’s natural ability to fight cancer. In just the past few years, the rapidly advancing field of cancer immunology has produced several new methods of treating cancer that increase the strength of immune responses against tumors.	abnormal cells 0.352853 CAR T cells 0.324531 cancer cells 0.817652 immune system activity 0.227645 immune responses 0.409806 toxic substance 0.204832 dendritic cells 0.272111 immune system molecules 0.223265 white blood cells 0.307219 activated T cells 0.296761 immune system—research 0.253725 immune response 0.250155 advanced lung cancer 0.212796 cancer treatment vaccine 0.201283 clinical trials 0.278634 tumor cells 0.49599 CD20-expressing cells 0.269956 normal cells 0.295119 human clinical trials 0.248944	antibody-dependent cell-mediated cytotoxicity 0.250246 patients 0.23385 advanced melanoma 0.22903 immune cells 0.680701 immune checkpoint inhibitors 0.313495 FDA-approved checkpoint inhibitors 0.216978 therapeutic antibodies 0.216622 cancer cell death 0.250231 immunotherapy uses proteins 0.212508 CAR T-cell therapy 0.397055 natural killer cells 0.304861 lymphoma cells 0.266327 cells 0.903811 different checkpoint protein 0.207351 modified T cells 0.282987 immune checkpoint proteins 0.3798 existing T cells 0.321978 certain immune cells 0.38886	CLICK HERE
16637	National Cancer Institute	Html	en	Metformin: Can a Diabetes Drug Help Prevent Cancer?	An article about the diabetes drug metformin, which research suggests may help prevent cancer.	metformin derivative 0.623089 cancer treatment 0.490275 study participants 0.484909 Dr. Heckman-Stoddard 0.535865 Family Comprehensive Cancer 0.513801 metformin arm 0.64832 early-phase prevention trials 0.505251 substantially lower risk 0.487063 original metformin formulation 0.653789 extensive laboratory research 0.487291 conventional antidiabetic doses 0.482196 Phase Prevention Trials 0.510585 clinical trials 0.598194 DPP Outcomes Study 0.570815 early-stage breast cancer 0.516459 laboratory studies 0.518492 Cancer Center 0.508828 Dr. Pollak 0.522365 triple-negative breast cancer 0.514736 postmenopausal breast cancer 0.520249 Dr. Zell 0.51558 cancer survivors 0.511148 Diego Moores Cancer 0.510708 metformin treatment 0.637604 large epidemiologic studies 0.500626	breast cancer cells 0.511965 cancer prevention 0.554231 primary cancer 0.48954 certain blood biomarkers 0.485052 cancer outcomes 0.485417 metformin derivatives 0.623142 blood biomarkers 0.487459 smaller prevention trials 0.498934 metformin 0.934872 breast cancer 0.751317 metformin’s effect 0.638135 cancer development 0.510096 early-stage clinical trials 0.564264 metformin’s impact 0.702491 breast cancer recurrences 0.517045 cancer clinical trials 0.527071 Diabetes Prevention Program 0.513336 cancer risk 0.512957 early-phase clinical trial 0.492505 cancer 0.791776 prevention trials 0.556708 diabetes drug metformin 0.743736 cancer incidence 0.513399 Antonio Breast Cancer 0.515009	CLICK HERE